Advertisement
Screener

PULMONX CORPORATION (LUNG) Patents: Applications Rejected

PULMONX CORPORATION Patent Applications Rejected

8 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-11-16: Application 18511782; Invention HIGH RESISTANCE IMPLANTED BRONCHIAL ISOLATION DEVICES AND METHODS; Applicant Pulmonx Corporation; Status Abandoned -- Failure to Respond to an Office Action.
  • 2022-03-16: Application 17696023; Invention SELECTIVE LUNG TISSUE ABLATION; Applicant Pulmonx Corporation; Status Abandoned -- Failure to Respond to an Office Action.
  • 2019-09-05: Application 16562158; Invention METHOD AND APPARATUS FOR ENDOBRONCHIAL DIAGNOSIS; Applicant Pulmonx Corporation; Status Abandoned -- Failure to Respond to an Office Action.
  • 2016-05-09: Application 15150324; Invention METHOD AND APPARATUS FOR ENDOBRONCHIAL DIAGNOSIS; Applicant PulmonX Corporation; Status Abandoned -- Failure to Respond to an Office Action.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2023-11-1618511782HIGH RESISTANCE IMPLANTED BRONCHIAL ISOLATION DEVICES AND METHODSPulmonx CorporationAbandoned -- Failure to Respond to an Office ActionUS20240156584A1
Sri Radhakrishnan
Ryan Olivera
United States
United States
ZIMMERMAN, REBECCA LYNEE
2022-03-1617696023SELECTIVE LUNG TISSUE ABLATIONPulmonx CorporationAbandoned -- Failure to Respond to an Office ActionUS20220202467A1
Peter P. Soltesz
Nikolai Aljuri
Ajit Nair
United States
United States
United States
PEFFLEY, MICHAEL F
2019-09-0516562158METHOD AND APPARATUS FOR ENDOBRONCHIAL DIAGNOSISPulmonx CorporationAbandoned -- Failure to Respond to an Office ActionUS20190388034A1
Robert Kotmel
Peter Soltesz
Anthony Wondka
Rodney Perkins
United States
United States
United States
United States
TOTH, KAREN E
2016-05-0915150324METHOD AND APPARATUS FOR ENDOBRONCHIAL DIAGNOSISPulmonX CorporationAbandoned -- Failure to Respond to an Office ActionUS20160249860A1
Robert Kotmel
Peter Soltesz
Anthony Wondka
Rodney Perkins
United States
United States
United States
United States
TOTH, KAREN E
2015-05-2814724400MEDICAL DEVICES AND METHODS FOR LUNG VOLUME REDUCTIONPulmonX CorporationAbandoned -- Failure to Respond to an Office ActionUS20150342610A1
Sri Radhakrishnan
Ryan Olivera
Hoang Nguyen
United States
United States
United States
SZPIRA, JULIE ANN
2015-02-1214621137METHODS AND SYSTEMS FOR ENDOBRONCHIAL DIAGNOSIS AND TREATMENTPulmonx CorporationAbandoned -- Failure to Respond to an Office ActionUS20150150486A1
Surag Mantri
Srikanth Radhakrishnan
United States
United States
PENG, BO JOSEPH
2014-12-1614571873Lung Volume Reduction Therapy Using Crosslinked BiopolymersPulmonxAbandoned -- Failure to Respond to an Office ActionUS20150196682A1
Larry W. Tsai
Edward P. Ingenito
United States
United States
WESTERBERG, NISSA M
2013-05-2213900082DEVICES, METHODS, AND SYSTEMS FOR DELIVERING IMPLANTS TO A LUNG REGIONPulmonX CorporationAbandoned -- Failure to Respond to an Office ActionUS20130317293A1
Ryan Olivera
Hoang NGUYEN
United States
United States
NEAL, TIMOTHY JAY

Similar stocks

Stock NameCountryMarket CapPE Ratio
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
Microbot Medical Inc. (MBOT)$0.089B-7.97
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
CVRx, Inc. (CVRX)United States$0.067B-2.62
DarioHealth Corp. (DRIO)$0.066B-1.39
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B